These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Neuroleptic malignant syndrome: guidelines for treatment and reinstitution of neuroleptics. Olmsted TR South Med J; 1988 Jul; 81(7):888-91. PubMed ID: 2899358 [TBL] [Abstract][Full Text] [Related]
10. On the early recognition of neuroleptic malignant syndrome. Clark T; Ananth J; Dubin S Int J Psychiatry Med; 1985-1986; 15(4):299-310. PubMed ID: 3830938 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis and Treatment of Neuroleptic Malignant Syndrome in the Intensive Care Unit: A Case Report. Maia A; Cotovio G; Barahona-Corrêa B; Oliveira-Maia AJ Acta Med Port; 2021 Jun; 34(6):464-467. PubMed ID: 32997617 [TBL] [Abstract][Full Text] [Related]
13. Neuroleptic malignant syndrome. Rampertaap MP South Med J; 1986 Mar; 79(3):331-6. PubMed ID: 3513330 [TBL] [Abstract][Full Text] [Related]
14. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management. Perry PJ; Wilborn CA Ann Clin Psychiatry; 2012 May; 24(2):155-62. PubMed ID: 22563571 [TBL] [Abstract][Full Text] [Related]
15. Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy. Hashim H; Zeb-un-Nisa ; Alrukn SA; Al Madani AA J Pak Med Assoc; 2014 Apr; 64(4):471-3. PubMed ID: 24864649 [TBL] [Abstract][Full Text] [Related]
18. A hazardous side effect of neuroleptics: diagnosis and treatment. Epperly TD; McGlaughlin VG; Leo KU Geriatrics; 1990 Aug; 45(8):58-62. PubMed ID: 1974232 [TBL] [Abstract][Full Text] [Related]